HIMS vs. SYK: Hims & Hers Health vs. Stryker Stock Comparison

Company Profile

Hims & Hers Health (HIMS) and Stryker (SYK) both fall under the Health Care Equipment & Services industry group, but HIMS is classified in Health Care Providers & Services while SYK is classified in Health Care Equipment & Supplies.

Stryker (SYK) has more than two decades of public-market history since March 17, 1980, whereas Hims & Hers Health (HIMS) listed on September 13, 2019 and has a much shorter record to draw on.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Hims & Hers Health (HIMS) carries a highly aggressive beta of 2.42, indicating much higher sensitivity to broad-market moves, whereas Stryker (SYK) is closer to market-like at 0.77 — a noticeable difference in market-sensitivity profile.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Hims & Hers Health (HIMS) reports a negative ROE of -2.66%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Stryker (SYK) reports 16.51%, ranking against industry peers normally.

Hims & Hers Health (HIMS) reports a negative net margin of -0.56%, usually indicating a net loss over the period. Meanwhile Stryker (SYK) reports 14.43%, ranking against industry peers normally.

Hims & Hers Health (HIMS) reports a negative operating margin of -7.90%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Stryker (SYK) reports 27.02%, ranking against industry peers normally.

Profitability Metrics

Growth

Hims & Hers Health (HIMS) at 59.00% clears its industry range for revenue growth, far stronger top-line momentum than Stryker (SYK) at 11.16%, which is closer to a typical peer reading.

Both Hims & Hers Health (HIMS) at -3.77% and Stryker (SYK) at 8.25% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

Growth Metrics

Financial Strength

Both Hims & Hers Health (HIMS) at 1.69 and Stryker (SYK) at 2.16 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.

Stryker (SYK) at 0.64 is near its industry mid-range for debt-to-equity ratio, while Hims & Hers Health (HIMS) at 2.54 sits above its benchmark range, pointing to a heavier debt load relative to equity.

Financial Strength Metrics

Dividends

Hims & Hers Health (HIMS) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Stryker (SYK) reports a yield of 1.03%, ranking against industry peers normally.

Hims & Hers Health (HIMS) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Stryker (SYK) reports a payout of 36.06%, ranking against industry peers normally.

Dividend Metrics

Valuation

An earnings multiple is available for just one side: Stryker (SYK) trades at 34.95 times trailing earnings, ranked against its peers, while Hims & Hers Health (HIMS) has no P/E ratio this period.

Hims & Hers Health (HIMS) at 3.09 is priced about in line with its industry on P/S ratio, while Stryker (SYK) at 5.03 sits in the pricier quartile — SYK costs more per dollar of sales.

Stryker (SYK) at 5.66 sits near its industry’s typical P/B ratio, while Hims & Hers Health (HIMS) at 16.33 prices above its benchmark range — HIMS looks rich relative to book.

Valuation Metrics